EDIT:NASDAQ
Editas Medicine Inc
US$ 2.17
arrow_upward
+1.40%(+0.030) Siku 1
13 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EDIT...
Fungua
US$ 2.14
Juu
US$ 2.21
Chini
US$ 2.01
Mtaji wa soko
334.92M
Wastani wa kiasi cha mauzo
2.42M
Kiasi cha mauzo ya hisa
2.79M
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Fungua
US$ 2.14
Juu
US$ 2.21
Chini
US$ 2.01
Mtaji wa soko
334.92M
Wastani wa kiasi cha mauzo
2.42M
Kiasi cha mauzo ya hisa
2.79M
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Motley Fool
·
saa 1 iliyopita
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
BigGo Finance
·
saa 6 zilizopita
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
24/7 Wall St.
·
saa 4 zilizopita
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
Traders Union
·
saa 4 zilizopita
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Wasifu
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Kuhusu Editas Medicine Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi87
LilianzishwaNov 2013
Makao makuu-
SektaHealth Care
Sekta-
Tovutieditasmedicine.com